Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trial by Aashish, Mondal, Arindam, Naskar, Siddiqi, Sheelu Shafiq, Bhosle, Deepak, Mallikarjuna, V J, Amol, Dange, Sanket, Sorate, Omkar, Gavali, Parth, Patel, Dhruvi, Hasnani, Durga, Prasad, Pradeep, Dalwadi, Suresh, Kumar, Vaishali, Pathak, Mayura, Chaudhari, Indraneel, Basu, Jayashri, Shembalkar, Arif, Fariooqui, Raghavendra, S K, Deepak, Varade, Ravindra, Thakkar, Shaishav, Bhanushali, Vijay, Gaikwad, Khan, Kamran, Mahajani, V V, Sharma, A D, Mayabhate, Mayur, Pawar, R R, Aiwale, A S, Vinayaka, Shahavi

Get full text